Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 78590-17-7
2. Prasterone Sulfate Sodium Hydrate
3. Prasterone Sodium Sulfate Dihydrate
4. E1cr8487en
5. Dehydroisoandrosterone 3-sulfate Sodium Salt Dihydrate
6. Sodium;[(3s,8r,9s,10r,13s,14s)-10,13-dimethyl-17-oxo-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl] Sulfate;dihydrate
7. Sodium Prasterone Sulfate [jan]
8. Prasterone Sulfate Sodium Salt Dihydrate
9. Unii-e1cr8487en
10. Mylis (tn)
11. Ncgc00093811-01
12. Dsstox_cid_25764
13. Dsstox_rid_81106
14. Dsstox_gsid_45764
15. Chembl3188432
16. Dtxsid9045764
17. Chebi:32148
18. Tox21_111223
19. 3-(sulfooxy)androst-5-en-17-one Sodium Salt, Dihydrate, (3beta)-
20. Androst-5-en-17-one, 3-(sulfooxy)-, Sodium Salt, Dihydrate, (3beta)-
21. Sodium Prasterone Sulfate Hydrate
22. Sodium Prasterone Sulfate Hydrate (jp17)
23. Cas-78590-17-7
24. D01616
25. Prasterone Sodium Sulfate Hydrate [jan]
26. 5-androsten-3beta-ol-17-one Sulphate,sodium Salt
27. Q27276745
28. 5-androsten-3b-ol-17-one Sulfate Sodium Salt Dihydrate
29. Dehydroepiandrosterone Sulfate Sodium Salt Dihydrate
30. 3.beta.-hydroxy-5-androsten-17-one Sodium Sulfate Dihydrate
31. Androst-5-en-17-one, 3-(sulfooxy)-, Sodium Salt, Dihydrate, (3.beta.)-
32. Androst-5-en-17-one, 3.beta.-hydroxy-, Hydrogen Sulfate, Sodium Salt, Dihydrate
33. Dehydroisoandrosterone 3-sulfate Sodium Salt Dihydrate, >=93% (tlc), Powder
| Molecular Weight | 426.5 g/mol |
|---|---|
| Molecular Formula | C19H31NaO7S |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 2 |
| Exact Mass | 426.16881878 g/mol |
| Monoisotopic Mass | 426.16881878 g/mol |
| Topological Polar Surface Area | 93.9 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 727 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 6 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 4 |
ABOUT THIS PAGE
A Sodium Prasterone Sulfate Dihydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sodium Prasterone Sulfate Dihydrate, including repackagers and relabelers. The FDA regulates Sodium Prasterone Sulfate Dihydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sodium Prasterone Sulfate Dihydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sodium Prasterone Sulfate Dihydrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Sodium Prasterone Sulfate Dihydrate supplier is an individual or a company that provides Sodium Prasterone Sulfate Dihydrate active pharmaceutical ingredient (API) or Sodium Prasterone Sulfate Dihydrate finished formulations upon request. The Sodium Prasterone Sulfate Dihydrate suppliers may include Sodium Prasterone Sulfate Dihydrate API manufacturers, exporters, distributors and traders.
click here to find a list of Sodium Prasterone Sulfate Dihydrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Sodium Prasterone Sulfate Dihydrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Sodium Prasterone Sulfate Dihydrate active pharmaceutical ingredient (API) in detail. Different forms of Sodium Prasterone Sulfate Dihydrate DMFs exist exist since differing nations have different regulations, such as Sodium Prasterone Sulfate Dihydrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Sodium Prasterone Sulfate Dihydrate DMF submitted to regulatory agencies in the US is known as a USDMF. Sodium Prasterone Sulfate Dihydrate USDMF includes data on Sodium Prasterone Sulfate Dihydrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sodium Prasterone Sulfate Dihydrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Sodium Prasterone Sulfate Dihydrate suppliers with USDMF on PharmaCompass.
Sodium Prasterone Sulfate Dihydrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sodium Prasterone Sulfate Dihydrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sodium Prasterone Sulfate Dihydrate GMP manufacturer or Sodium Prasterone Sulfate Dihydrate GMP API supplier for your needs.
A Sodium Prasterone Sulfate Dihydrate CoA (Certificate of Analysis) is a formal document that attests to Sodium Prasterone Sulfate Dihydrate's compliance with Sodium Prasterone Sulfate Dihydrate specifications and serves as a tool for batch-level quality control.
Sodium Prasterone Sulfate Dihydrate CoA mostly includes findings from lab analyses of a specific batch. For each Sodium Prasterone Sulfate Dihydrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sodium Prasterone Sulfate Dihydrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Sodium Prasterone Sulfate Dihydrate EP), Sodium Prasterone Sulfate Dihydrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sodium Prasterone Sulfate Dihydrate USP).
LOOKING FOR A SUPPLIER?
